Real-time enrollment status for this chronic lymphocytic leukemia (cll) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:13 PM UTC
| NCT Number | NCT06788639 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukemia (CLL) |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
| Last Updated on CT.gov | February 24, 2025 (Feb 24, 2025) |
As of July 18, 2026: Clinical trial NCT06788639 is currently recruiting participants. This clinical trial study for chronic lymphocytic leukemia (cll) is actively seeking new participants at 1 location across the United States. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06788639 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06788639 was last updated Feb 24, 2025 (February 24, 2025). HelloStudys verifies this status automatically.